» Articles » PMID: 26110395

Geographic Distribution and Characteristics of Genotype A Hepatitis B Virus Infection in Acute and Chronic Hepatitis B Patients in Japan

Abstract

Background And Aims: The prevalence of sexually transmitted acute infections of the genotype A hepatitis B virus (HBV) has been increasing in Japan. Genotype A HBV is associated with an increased risk of HBV progression to chronic infection after acute hepatitis B (AHB) in adults. A nationwide survey was conducted to evaluate the geographic distribution, clinical, and virologic characteristics of genotype A AHB and chronic hepatitis B (CHB) in Japan.

Methods: Five hundred seventy AHB patients were recruited between 2005 and 2010, and 3682 CHB patients were recruited between 2010 and 2011. HBV genotypes were determined for 552 and 3619 AHB and CHB patients, respectively. Clinical characteristics were compared among different genotypes in AHB and CHB patients. Genomic characteristics of HBV genotype A were examined by molecular evolutionary analysis.

Results: Hepatitis B virus genotype A was the predominant genotype for AHB between 2005 and 2010. Phylogenetic analysis showed that all strains in the AHB patients with genotype A were classified into subtype Ae. Among CHB patients, the occurrence of genotype A was 4.1%, and genotype A was spreading in young adults. In genotype A CHB patients, early stage liver diseases were predominant, although liver diseases progressed to cirrhosis or hepatocellular carcinoma in some patients.

Conclusions: The distribution of HBV genotypes is quite different between AHB and CHB in Japanese patients. Genotype A infection is spreading in young adults of Japanese CHB patients. Sequences derived from Japanese AHB patients were identical to or closely resembled the sequences derived from other Japanese AHB patients.

Citing Articles

Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues.

Inoue J, Minami S, Abe K, Kida M, Haga H, Iino C J Viral Hepat. 2025; 32(4):e70021.

PMID: 40052685 PMC: 11887419. DOI: 10.1111/jvh.70021.


Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study.

Adewuyi O, Balogun M, Otomaru H, Abimiku A, Ahumibe A, Ilori E Pathogens. 2025; 14(1).

PMID: 39861062 PMC: 11768191. DOI: 10.3390/pathogens14010101.


Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan.

Sakamoto K, Ito K, Yotsuyanagi H, Yatsuhashi H, Tanaka Y, Hige S J Gastroenterol. 2022; 57(12):971-980.

PMID: 36173513 DOI: 10.1007/s00535-022-01921-4.


Hepatitis B Virus Infection among Japanese Immigrants and Descendants: The Need to Strengthen Preventive and Control Measures.

Demarchi L, Bandeira L, Taira D, Zardin M, Ibanhes M, Esposito A Viruses. 2022; 14(5).

PMID: 35632826 PMC: 9145874. DOI: 10.3390/v14051085.


Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study.

Inoue J, Kobayashi T, Akahane T, Kimura O, Sato K, Ninomiya M J Clin Med. 2022; 11(9).

PMID: 35566481 PMC: 9101732. DOI: 10.3390/jcm11092354.